While several studies have reported the antiproliferative effect of gli in several cancer cell lines [15,16,17], there are also data suggesting that gli increases the risk of cancer in diabetes, a disease in which inflammation is one of the risk factors [18,19]. This evidence concerns the gene GLI1 and diabetes mellitus.